CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Study suggests $35 monthly insulin cap has increased patient access

insulinPositive
AI Analysis

Summary

A study shows that Medicare patients with diabetes experienced reduced out-of-pocket insulin costs and improved treatment adherence following implementation of the $35 monthly insulin cap in 2023.

Importance:3/10
Sentiment:
0.60
Medicareinsulin pricingpatient accesspolicy impactmedication adherence
Related Companies

Read the original article

Published by Endpoints News on April 7, 2026 6:52 PM

Read Original